Publicerad: 2016-04-26 13:21 | Uppdaterad: 2016-04-26 13:24
Tore Curstedt är en av finalisterna i European Inventor Award 2016
Vi gratulerar Tore Curstedt, från gruppen Klinisk kemi och koagulation, som är nominerad till the European Inventor Award 2016 i i kategorin Lifetime achievement!
Tore Curstedt har tillsammans med sin kollega Bengt Robertsson utvecklat en behandlingsmetod för prematura barn som lider av respiratory distress syndrome (RDS), ett andnödssyndrom som varit den ledande dödsorsaken bland nyfödda i årtionden. Behandlingsmetoden används idag i 80 länder och bedöms ha räddat livet på över en halv miljon för tidigt födda barn.
På the European Patent Office - www.epo.org kan du läsa mer om behandlingsmetoden och även rösta på Tore Curstedt.
Docent
Tore Curstedt
| Telefon: | 08-517 760 82 |
| Enhet: | Klinisk kemi och koagulation |
| E-post: | tore.curstedt@ki.se |
About the European Inventor Award - Celebrating the spirit of innovation
"The driving force behind the innovation process is people - people with a passion for discovery. Without their inquisitive minds, their quest for new ideas and their creativity, there would be no inventive spirit and no progress. As one of the most prestigious competitions of its kind, the European Inventor Award pays tribute to the creativity of inventors the world over, who use their technical, scientific and intellectual skills to make a real contribution to technological progress and economic growth and so improve people's daily lives."
"The driving force behind the innovation process is people - people with a passion for discovery. Without their inquisitive minds, their quest for new ideas and their creativity, there would be no inventive spirit and no progress. As one of the most prestigious competitions of its kind, the European Inventor Award pays tribute to the creativity of inventors the world over, who use their technical, scientific and intellectual skills to make a real contribution to technological progress and economic growth and so improve people's daily lives."